Cargando…

The mechanism of resistance to favipiravir in influenza

Favipiravir is a broad-spectrum antiviral that has shown promise in treatment of influenza virus infections. While emergence of resistance has been observed for many antiinfluenza drugs, to date, clinical trials and laboratory studies of favipiravir have not yielded resistant viruses. Here we show e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goldhill, Daniel H., te Velthuis, Aartjan J. W., Fletcher, Robert A., Langat, Pinky, Zambon, Maria, Lackenby, Angie, Barclay, Wendy S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2018
Materias:	Biological Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233120/ https://www.ncbi.nlm.nih.gov/pubmed/30352857 http://dx.doi.org/10.1073/pnas.1811345115

Ejemplares similares

Determining the Mutation Bias of Favipiravir in Influenza Virus Using Next-Generation Sequencing
por: Goldhill, Daniel H., et al.
Publicado: (2019)

Favipiravir-resistant influenza A virus shows potential for transmission
por: Goldhill, Daniel H., et al.
Publicado: (2021)

Pandemic H1N1 2009 influenza virus with the H275Y oseltamivir resistance neuraminidase mutation shows a small compromise in enzyme activity and viral fitness
por: Brookes, Daniel W., et al.
Publicado: (2011)

A Mechanism for Priming and Realignment during Influenza A Virus Replication
por: Oymans, Judith, et al.
Publicado: (2018)

Single-molecule FRET reveals the pre-initiation and initiation conformations of influenza virus promoter RNA
por: Robb, Nicole C., et al.
Publicado: (2016)

Influenza Virus RNA Synthesis and the Innate Immune Response
por: Weis, Sabrina, et al.
Publicado: (2021)

The influenza virus RNA polymerase as an innate immune agonist and antagonist
por: Elshina, Elizaveta, et al.
Publicado: (2021)

Structure of the SARS-CoV-2 RNA-dependent RNA polymerase in the presence of favipiravir-RTP
por: Naydenova, Katerina, et al.
Publicado: (2021)

Initiation, Elongation, and Realignment during Influenza Virus mRNA Synthesis
por: te Velthuis, Aartjan J. W., et al.
Publicado: (2018)

Oseltamivir-Resistant Influenza Virus A (H1N1), Europe, 2007–08 Season
por: Meijer, Adam, et al.
Publicado: (2009)

Oseltamivir-Resistant Influenza Viruses A (H1N1), Norway, 2007–08
por: Hauge, Siri H., et al.
Publicado: (2009)

Favipiravir at high doses has potent antiviral activity in SARS-CoV-2−infected hamsters, whereas hydroxychloroquine lacks activity
por: Kaptein, Suzanne J. F., et al.
Publicado: (2020)

Role of the PB2 627 Domain in Influenza A Virus Polymerase Function
por: Nilsson, Benjamin E., et al.
Publicado: (2017)

Transient RNA structures cause aberrant influenza virus replication and innate immune activation
por: French, Hollie, et al.
Publicado: (2022)

Influenza Virus with Increased pH of Hemagglutinin Activation Has Improved Replication in Cell Culture but at the Cost of Infectivity in Human Airway Epithelium
por: Singanayagam, Anika, et al.
Publicado: (2019)

The Combined Effect of Oseltamivir and Favipiravir on Influenza A Virus Evolution
por: Ormond, Louise, et al.
Publicado: (2017)

Do point-of-care tests (POCTs) offer a new paradigm for the management of patients with influenza?
por: Dickson, Elizabeth M, et al.
Publicado: (2020)

Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus Infection in England and Scotland, 2009–2010
por: Calatayud, Laurence, et al.
Publicado: (2011)

Levels of Influenza A Virus Defective Viral Genomes Determine Pathogenesis in the BALB/c Mouse Model
por: Penn, Rebecca, et al.
Publicado: (2022)

ANP32 Proteins Are Essential for Influenza Virus Replication in Human Cells
por: Staller, Ecco, et al.
Publicado: (2019)

Mouse Models of Influenza Infection with Circulating Strains to Test Seasonal Vaccine Efficacy
por: Groves, Helen T., et al.
Publicado: (2018)

Relative role of community transmission and campus contagion in driving the spread of SARS-CoV-2: Lessons from Princeton University
por: Park, Sang Woo, et al.
Publicado: (2023)

Uncoupling of Influenza A Virus Transcription and Replication through Mutation of the Unpaired Adenosine in the Viral RNA Promoter
por: te Velthuis, Aartjan J. W., et al.
Publicado: (2013)

Contact transmission of influenza virus between ferrets imposes a looser bottleneck than respiratory droplet transmission allowing propagation of antiviral resistance
por: Frise, Rebecca, et al.
Publicado: (2016)

Understanding the pharmacokinetics of Favipiravir: Implications for treatment of influenza and COVID-19
por: Ison, Michael G., et al.
Publicado: (2021)

Low ambient humidity impairs barrier function and innate resistance against influenza infection
por: Kudo, Eriko, et al.
Publicado: (2019)

The Host Factor ANP32A Is Required for Influenza A Virus vRNA and cRNA Synthesis
por: Nilsson-Payant, Benjamin E., et al.
Publicado: (2022)

Real-time analysis of single influenza virus replication complexes reveals large promoter-dependent differences in initiation dynamics
por: Robb, Nicole C, et al.
Publicado: (2019)

Common and unique features of viral RNA-dependent polymerases
por: te Velthuis, Aartjan J. W.
Publicado: (2014)

Single-Cell Virus Sequencing of Influenza Infections That Trigger Innate Immunity
por: Russell, Alistair B., et al.
Publicado: (2019)

Mutual information networks reveal evolutionary relationships within the influenza A virus polymerase
por: Arcos, Sarah, et al.
Publicado: (2023)

Mutual information networks reveal evolutionary relationships within the influenza A virus polymerase
por: Arcos, Sarah, et al.
Publicado: (2023)

Deep mutational scanning reveals the functional constraints and evolutionary potential of the influenza A virus PB1 protein
por: Li, Yuan, et al.
Publicado: (2023)

Mammalian ANP32A and ANP32B Proteins Drive Differential Polymerase Adaptations in Avian Influenza Virus
por: Peacock, Thomas P., et al.
Publicado: (2023)

Dissecting the mechanism of signaling-triggered nuclear export of newly synthesized influenza virus ribonucleoprotein complexes
por: Schreiber, André, et al.
Publicado: (2020)

Feasibility and clinical utility of local rapid Nanopore influenza A virus whole genome sequencing for integrated outbreak management, genotypic resistance detection and timely surveillance
por: Williams, Tom G. S., et al.
Publicado: (2023)

Favipiravir, an anti-influenza drug against life-threatening RNA virus infections
por: Shiraki, Kimiyasu, et al.
Publicado: (2020)

Decoding the Role of Temperature in RNA Virus Infections
por: Bisht, Karishma, et al.
Publicado: (2022)

Influenza A Virus Defective Viral Genomes Are Inefficiently Packaged into Virions Relative to Wild-Type Genomic RNAs
por: Alnaji, Fadi G., et al.
Publicado: (2021)

ICU admission and favipiravir
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jjg2qp31qrbov8mv0dvhl88k0t